These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16131808)

  • 1. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
    Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
    Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
    Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
    Mortier S; Faict D; Lameire NH; De Vriese AS
    Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
    Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
    Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
    Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
    Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
    Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
    Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.
    Mortier S; De Vriese AS; Van de Voorde J; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2002 Feb; 13(2):480-489. PubMed ID: 11805178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of peritoneal dialysis solutions on peritoneal host defense.
    Mortier S; Lameire NH; De Vriese AS
    Perit Dial Int; 2004; 24(2):123-38. PubMed ID: 15119633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
    Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
    Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
    Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions.
    ter Wee PM; Beelen RH; van den Born J
    Kidney Int Suppl; 2003 Dec; (88):S75-83. PubMed ID: 14870880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
    Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.
    MacKenzie RK; Holmes CJ; Moseley A; Jenkins JP; Williams JD; Coles GA; Faict D; Topley N
    J Am Soc Nephrol; 1998 Aug; 9(8):1499-506. PubMed ID: 9697673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.
    Brulez HF; Dekker HA; Oe PL; Verbeelen D; ter Wee PM; Verbrugh HA
    Nephron; 1996; 74(1):26-32. PubMed ID: 8883016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer-Period Effects of Bicarbonate/Lactate-Buffered Neutral Peritoneal Dialysis Fluid in Patients Undergoing Peritoneal Dialysis.
    Hoshino T; Kaneko S; Minato S; Yanai K; Mutsuyoshi Y; Ishii H; Kitano T; Shindo M; Miyazawa H; Aomatsu A; Ito K; Ueda Y; Hirai K; Ookawara S; Morishita Y
    Ther Apher Dial; 2018 Dec; 22(6):641-648. PubMed ID: 30014626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.